Compile Data Set for Download or QSAR
Report error Found 41 Enz. Inhib. hit(s) with all data for entry = 9439
TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391987(tert-Butyl {2-[(1S)-1- ({[(4- chlorophenyl)amino] ...)
Affinity DataEC50:  361nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391977(3-{2-[1-({[4- (Trifluoromethyl)phenyl] carbamoyl}a...)
Affinity DataEC50:  23nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391978(Ethyl 3-[2-(1-{[(4- Bromophenyl)carbamoyl] amino}p...)
Affinity DataEC50:  1.21E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391979(Ethyl 3-[2-(1-{[(4- Bromophenyl)carbamoyl] amino}e...)
Affinity DataEC50:  734nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391980(Ethyl 3-{2-[1-({[4- (trifluoromethyl)phenyl] carba...)
Affinity DataEC50:  1.11E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391981({2-[(1S)-1-{[(4- Bromophenyl)carbamoyl] amino}buty...)
Affinity DataEC50:  173nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391982({2-[(1S)-1-{[(4- Bromophenyl)carbamoyl] amino}-2- ...)
Affinity DataEC50:  46nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391983(1-[(1S)-1-(1H-imidazol- 2-yl)-2-methylpropyl]- 3-[...)
Affinity DataEC50:  4nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391984(1-(4-Chlorophenyl)-3- [(1S)-1-(1H-imidazol-2- yl)-...)
Affinity DataEC50:  9nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391985(1-(4-Bromo-2- fluorophenyl)-3-[(1S)-1- (1H-imidazo...)
Affinity DataEC50:  8nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391986(1-[(1S)-1-(1H-imidazol- 2-yl)-2-methylpropyl]- 3-(...)
Affinity DataEC50:  109nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391976({2-[1-({[4- (Trifluoromethyl)phenyl] carbamoyl} am...)
Affinity DataEC50:  6.60nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391988(tert-Butyl {2-[(1S)-1- ({[(4-bromo-2- fluorophenyl...)
Affinity DataEC50:  855nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391989(tert-Butyl {2-[(1S)-1- ({[(4- methoxyphenyl)amino]...)
Affinity DataEC50:  139nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391990((2-{(1S)-2-Methyl-1- [({[4- (trifluoromethyl)pheny...)
Affinity DataEC50:  3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391991({2-[(1S)-1-({[(4- Chlorophenyl)amino] carbonyl}ami...)
Affinity DataEC50:  40nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391992({2-[(1S)-1-({[(4-bromo- 2-fluorophenyl)amino] carb...)
Affinity DataEC50:  14nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391993({2-[(1S)-1-({[(4- methoxyphenyl)amino] carbonyl}am...)
Affinity DataEC50:  106nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391994(2-(2-{(1S)-2-methyl-1- [({[4-(trifluoromethyl) phe...)
Affinity DataEC50:  43nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391995(2-(2-{(1S)-2-methyl-1- [({[4-(trifluoromethyl) phe...)
Affinity DataEC50:  206nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391996(N,N-Dimethyl-2-(2- {(1S)-2-methyl-1-[({[4- (triflu...)
Affinity DataEC50:  277nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391966(US10301269, Number 11 | Ethyl [2-({[(4- Bromopheny...)
Affinity DataEC50:  400nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391957(US10301269, Number 2 | 1-(4-Bromophenyl)-3- [(1S)-...)
Affinity DataEC50:  2.07E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391958(US10301269, Number 3 | 1-(4-Bromophenyl)-3- [(1S)-...)
Affinity DataEC50:  46nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391959(US10301269, Number 4 | 1-(4-Bromophenyl)-3- (1H-im...)
Affinity DataEC50:  175nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391960(US10301269, Number 5 | 1-(4-Bromophenyl)-3- [1-(1H...)
Affinity DataEC50:  401nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391961(US10301269, Number 6 | 1-[1-(1H-Imidazol-2- yl)pro...)
Affinity DataEC50:  199nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391962(US10301269, Number 7 | Ethyl [2-(1-{[(4- Bromophen...)
Affinity DataEC50:  439nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391963(US10301269, Number 8 | Ethyl {2-[(1S)-1-{[(4- brom...)
Affinity DataEC50:  1.09E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391964(US10301269, Number 9 | tert-Butyl {2-[(1S)-1- {[(4...)
Affinity DataEC50:  1.29E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391965(US10301269, Number 10 | tert-Butyl {2-[(1S)-1- {[(...)
Affinity DataEC50:  1.11E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391956(US10301269, Number 1 | 1-(4-Bromophenyl)-3- [1-(1H...)
Affinity DataEC50:  898nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391967(US10301269, Number 12 | Ethyl [2-(1-{[(4- Bromophe...)
Affinity DataEC50: >2.00E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391968(US10301269, Number 13 | 1-(4-Bromophenyl)-3- {1-[1...)
Affinity DataEC50:  200nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391969(US10301269, Number 14 | Ethyl 2-[2-({[(4- Bromophe...)
Affinity DataEC50:  584nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391970(US10301269, Number 15 | Ethyl {2-[1-({[4- (trifluo...)
Affinity DataEC50:  332nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391971(US10301269, Number 16 | [2-(1-{[(4- Bromophenyl)ca...)
Affinity DataEC50:  47nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391972(US10301269, Number 17 | [2-({[(4- Bromophenyl)carb...)
Affinity DataEC50:  3.28E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391973(US10301269, Number 18 | [2-(1-{[(4- Bromophenyl)ca...)
Affinity DataEC50:  30nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391974(US10301269, Number 19 | 2-[2-({[(4- Bromophenyl)ca...)
Affinity DataEC50:  270nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM391975(3-[2-(1-{[(4- Bromophenyl)carbamoyl] amino}propyl)...)
Affinity DataEC50:  42nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent